Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.89 |
| ▸ | CHAT | P28329 | 2/20 | 0.85 |
| ▸ | EP300 | Q09472 | 3/20 | 0.84 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.84 |
| ▸ | AURKA | O14965 | 2/20 | 0.84 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.84 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4368641 | 1.00 | NAA50 (0.89) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL25252 | 1.00 | NAA50 (0.89) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL27877871 | 1.00 | NAA50 (0.89) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL27571436 | 1.00 | NAA50 (0.89) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL26116845 | 1.00 | NAA50 (0.89) | NAA50CHATEP300KAT5AURKA | |
| Charcoal, Activated SCHEMBL1644250 | 0.99 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| Benzene SCHEMBL27562050 | 0.99 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| Acetic Acid SCHEMBL876317 | 0.98 | NAA50 (0.88) | NAA50CHATEP300KAT5AURKA | |
| Succinic Acid SCHEMBL23245911 | 0.98 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Succinic Acid SCHEMBL30638868 | 0.98 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 596 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3957736-B1 | PRODUCTION OF ODD CHAIN FATTY ACID DERIVATIVES IN RECOMBINANT MICROBIAL CELLS | GENOMATICA INC (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4537111-A2 | MULTI-OMICS ASSESSMENT | Prognomiq Inc (US) | 2025-04-16 | — | — | EP | claimed |
| EP-3119895-B1 | GENOME EDITING WITHOUT NUCLEASES | UNIV LELAND STANFORD JUNIOR (US) | 2023-12-20 | — | — | EP | claimed |
| EP-3488007-B1 | SCALABLE HIGH RECOVERY METHODS FOR PRODUCING HIGH YIELD RECOMBINANT ADENO-ASSOCIATED VIRAL (RAAV) VECTOR AND RECOMBINANT ADENO-ASSOCIATED VIRAL (RAAV) VECTORS PRODUCED THEREBY | SPARK THERAPEUTICS INC (US) | 2023-12-20 | — | — | EP | claimed |
| WO-2023240046-A2 | MULTI-OMICS ASSESSMENT | PrognomIQ, Inc. (US) | 2023-12-14 | — | — | WO | claimed |
| EP-3414334-B1 | PROCESS | VESTLANDETS INNOVASJONSSELSKAP AS (NO) | 2023-10-11 | — | — | EP | claimed |
| EP-2756090-B1 | PRODUCTION OF ODD CHAIN FATTY ACID DERIVATIVES IN RECOMBINANT MICROBIAL CELLS | GENOMATICA INC (US) | 2021-08-04 | — | — | EP | claimed |
| EP-2971022-B1 | ENGINEERED ORGANISMS FOR PRODUCTION OF NOVEL LIPIDS | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN (AR) | 2020-08-19 | — | — | EP | claimed |
| EP-3365427-B1 | MICROORGANISM MODIFIED FOR THE ASSIMILATION OF LEVULINIC ACID | METABOLIC EXPLORER SA (FR) | 2020-08-19 | — | — | EP | claimed |
| EP-3009135-B1 | PRECURSOR OF PROPIONYL COENZYME A FOR USE IN THE TREATMENT OF HUNTINGTON DISEASE AND OTHER POLYGLUTAMINE DISEASES | INST NAT SANTE RECH MED (FR) | 2020-02-05 | — | — | EP | claimed |
| EP-2566953-B1 | METHODS FOR CONTROL OF FLUX IN METABOLIC PATHWAYS THROUGH ENZYME RELOCATION | GREENLIGHT BIOSCIENCES INC (US) | 2019-01-02 | — | — | EP | claimed |
| EP-2524049-B1 | SCATTERED BRANCHED-CHAIN FATTY ACIDS AND BIOLOGICAL PRODUCTION THEREOF | PROCTER & GAMBLE (US) | 2015-10-28 | — | — | EP | claimed |
| EP-2097064-B1 | ANAPLEROTIC THERAPY OF HUNTINGTON DISEASE AND OTHER POLYGLUTAMINE DISEASES | INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE (FR) | 2015-08-19 | — | — | EP | claimed |
| EP-2329018-B1 | METHOD FOR THE ANNOTATION OF NATURAL PRODUCT GENE-CLUSTERS AND FOR THE GENERATION OF NOVEL BIOLOGICALLY ACTIVE CHEMICAL ENTITIES FROM DNA SEQUENCES IN SILICO | GENQUAD AG (CH) | 2014-09-10 | — | — | EP | claimed |
| CN-102625845-A | Microorganisms and methods for the synergistic production of isopropanol and primary alcohols, glycols and acids | GENOMATICA INC | 2012-08-01 | — | — | CN | claimed |
| WO-2011034397-A2 | METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | claimed |
| EP-0535012-B1 | HV/HB COPOLYMER PRODUCTION | ZENECA LTD (GB) | 1995-09-13 | — | — | EP | claimed |
| EP-4746864-A1 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION | Keto Innovations, LLC (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-1990000003-A1 | PURIFICATION AND CHARACTERIZATION OF AN ACETYL-COA HYDROLASE | THE GENERAL HOSPITAL CORPORATION (US) | 1990-01-11 | — | — | WO | disclosed |
| EP-0348958-A2 | Purification and characterization of an acetyl-CoA hydrolase | THE GENERAL HOSPITAL CORPORATION (US) | 1990-01-03 | — | — | EP | disclosed |